8.76 USD
↘ 0.57 (6.06%)LIVE (AS OF 01:55 PM EST)
Sutro Biopharma, Inc. (STRO) trades at $8.76 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (117.2%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, STRO appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.